Botanical species · safety record

Turnera diffusa

The EFSA Compendium of Botanicals holds 11 constituent measurements for Turnera diffusa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Turnera diffusa Willd. ex Schult.

11Constituent measurements
0Safety records
5Cited sources
272Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 272 licensed products naming Turnera diffusa as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA
  • fluid

Source material stated

  • Aged bark
  • Brindille feuillue
  • Dried leaves, flowers and young sections of stem collected at flowering time
  • Fruit extract
  • Grass(es)
  • Leaf
  • Leaf and stem
  • Leaf blade

What the records describe

Constituents measured

  • 1,8-cineole4
  • Cyanogenic glycosides2
  • Tannins2
  • Alkaloids1
  • Pinocarvone1
  • Saponins1

Plant parts

  • Unspecified7
  • Aerial part of plants3
  • Leaves1

Preparations

  • Solvent extraction7
  • Essential oil4

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
1,8-cineoleUnspecifiedEssential oil11.4 PercentGC-MSResolve DOI
1,8-cineoleAerial part of plantsEssential oil2.79 Percent AreaGaschromatography (GC)Resolve DOI
1,8-cineoleAerial part of plantsEssential oil1.846 Percent AreaGaschromatography (GC)Resolve DOI
1,8-cineoleUnspecifiedSolvent extractionUnspecifiedResolve DOI
AlkaloidsUnspecifiedSolvent extractionPhytochemical screeningResolve DOI
Cyanogenic glycosidesUnspecifiedSolvent extractionPhytochemical screeningResolve DOI
Cyanogenic glycosidesUnspecifiedSolvent extractionUnspecifiedResolve DOI
PinocarvoneAerial part of plantsEssential oil1.34 Percent AreaGaschromatography (GC)Resolve DOI
SaponinsUnspecifiedSolvent extractionPhytochemical screeningResolve DOI
TanninsUnspecifiedSolvent extractionPhytochemical screeningResolve DOI
TanninsLeavesSolvent extractionUnspecifiedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Alcaraz-Melendez, L., Delgado-Rodriguez, J., Real-Cosio, S. Analysis of essential oils from wild and micropropagated plants of damiana (Turnera diffusa) . Fitoterapia, 2004, vol. 75, no. 7-8, p. 696-701. DOI
  2. Kumar, S., Taneja, R., Sharma, A. Pharmacognostic standardization of Turnera aphrodisiaca Ward. Journal of medicinal food, 2006, vol. 9, no. 2, p. 254-260. DOI
  3. Steinmetz, E. F. Damianae folia. Acta phytotherapeut., 1960, p. 1-2.
  4. Godoi, AFL., Vilegas, W., Godoi, RHM., Van Vaeck, L., Van Grieken, R. Application of low-pressure gas chromatography-ion-trap mass spectrometry to the analysis of the essential oil of Turnera diffusa (Ward.) Urb.. JOURNAL OF CHROMATOGRAPHY A, 2004, vol. 1027, no. 1-2, p. 127-130. DOI
  5. Kumar, S., Taneja, R., Sharma, A. The genus Turnera: A review update. Pharmaceutical Biology, 2005, vol. 43, no. 5, p. 383-391. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue